Following PET-CT and mediastinoscopy with a biopsy, the left breast was found to have Stage IV high-grade infiltrating ductal carcinoma, 2.7 cm, that is ER/PR-, HER2+ with mediastinal metastatic lymphadenopathy. This evidence concerns the gene ERBB2 and invasive ductal breast carcinoma.